Enzastaurin Completed Phase 3 Trials for Non-Hodgkin's Lymphoma (NHL) Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00332202PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin